Sara Abalde-Cela, PhD profile page

Dr Sara Abalde-Cela is the Research Group Leader of the Medical Devices group at the International Iberian Nanotechnology Laboratory (INL), Braga, Portugal. The Medical Devices group focuses on the development of optofluidic platforms for the diagnosis and understanding of diseases. Sara holds a PhD in nanotechnology by the Universidade de Vigo and a postdoc in the field of microfluidics at the University of Cambridge. Sara has attracted +6 million € in competitive funding as a PI, such as Pathfinder, FET Open or RIA/IA Actions. She has also been active in teaching, science outreach and start-up programs internationally (Cambridge, London, Boston, Vigo, and Braga). Sara is also the co-founder and CTO of the start-up RUBYnanomed (2018 – now), having raised more than 5 million € for innovation to date. In 2022 she was nominated as finalist for Women Innovators Prize by the European Innovation Council.